Growth hormone therapy in patients with dilated cardiomyopathy: Preliminary observations of a pilot study

Indian Heart Journal

Volumn 51, Issue 2, 1999, Pages 183-185

  Jose, V Jacob ^a   Zechariah, T U ^a   George, Paul ^a   Jonathan, ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; HEART DILATATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HORMONAL THERAPY; HUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; GROWTH HORMONE; HUMANS; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 0032994536     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Fazio SD, Capaldo B, Vigorito C, et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996; 334: 809-814
2. Osterziel KJ, Strohm O, Schuler J, et al. Randomised double blind placebo controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998; 351: 1233-1237
3. Zotz SG, Zotz R, Geil S, Voigtlander T, Meyer J, Darius H. Recombinant growth hormone therapy in patients with ischaemic cardiomyopathy. Circulation 1999; 99: 18-21
4. Beshyah SA, Shahi M, Skinner E, et al. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. Eur J Endocrinol 1994; 130: 451-458
5. Capaldo B, Lembo G, Rendina V, et al. Sympathetic deactivation by growth hormone in patients with dilated cardiomyopathy. Eur Heart J 1998; 19: 623-627
6. Tajima M, Weinberg EO, Bartunek J, Jin H, Yang R, Paoni NF, Lorell BH. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation 1999; 99: 127-134
7. Dreifuss P. Growth hormone in dilated cardiomyopathy: Advantages and disadvantages [letter]. Eur Heart J 1999; 20: 243-244